Drug details:
Molecular formula: C₁₅H₁₂BrN₃OS

Standard name: 2-(1H-benzimidazol-2-ylsulfanyl)-N-(4-bromophenyl)acetamide

Synonyms:

2-((1H-benzo[d]imidazol-2-yl)thio)-N-(4-bromophenyl)acetamide 2-(1H-1,3-BENZODIAZOL-2-YLSULFANYL)-N-(4-BROMOPHENYL)ACETAMIDE 2-(1H-Benzoimidazol-2-ylsulfanyl)-N-(4-bromo-phenyl)-acetamide

Curated SMILES: O=C(CSC1=NC2=CC=CC=C2N1)NC1=CC=C(Br)C=C1

Evidence for compound's anti-virulence activity:

Pseudomonas
Related VFcategory: Biofilm
Target: MvfR
Drug effect: Inhibits MvfR-regulated virulence functions.
Max phase: Preclinical (in vitro)
Publication:
Starkey M, et al., 2014. Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. PLoS Pathog 10(8):e1004321.